Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,160 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01929993 | A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins | completed | Phase 3 | 164 | Oswaldo Cruz FoundationOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT00959400 | Efficacy and Safety Study of Fentanyl Transdermal (Fentanest®) | withdrawn | Phase 3 | 0 | Cristália Produtos Químicos Farmacêuticos Ltda.INDUSTRY | 1 | Jul 16, 2015 | clinicaltrials |
| NCT02495532 | Clinical Trial Comparing Carnoy's and GEWF Solutions for Lymph Node Clearing Technique in Colorectal Cancer | unknown | N/A | 126 | Hospital Moinhos de VentoOTHER | 1 | Jul 13, 2015 | clinicaltrials |
| NCT00995020 | Efficacy Study of Diathermy Cone Biopsy for the Treatment of Cervical Intraepithelial Lesion | completed | Phase 3 | 103 | Oswaldo Cruz FoundationOTHER | 1 | Jul 10, 2015 | clinicaltrials |
| NCT02487615 | Genetical, Anthropometrical and Biochemical Factors Influencing High Risk Subclinical Atherosclerosis | completed | — | 340 | Instituto Dante Pazzanese de CardiologiaOTHER | 1 | Jul 7, 2015 | clinicaltrials |
| NCT00510068 | Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors(RADIANT-3) | completed | Phase 3 | 410 | Novartis PharmaceuticalsINDUSTRY | 18 | Jul 1, 2015 | clinicaltrials |
| NCT01039272 | Epstein-Barr Detection in Oral Cancer | completed | — | 60 | UPECLIN HC FM Botucatu UnespOTHER | 1 | Jun 25, 2015 | clinicaltrials |
| NCT01103323 | Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy | completed | Phase 3 | 760 | BayerINDUSTRY | 19 | Jun 24, 2015 | clinicaltrials |
| NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | completed | Phase 3 | 2,296 | Hoffmann-La RocheINDUSTRY | 36 | May 25, 2015 | clinicaltrials |
| NCT01379534 | A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer | completed | Phase 2 | 53 | Novartis PharmaceuticalsINDUSTRY | 7 | May 20, 2015 | clinicaltrials |
| NCT00075270 | Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer | completed | Phase 3 | 580 | GlaxoSmithKlineINDUSTRY | 25 | May 6, 2015 | clinicaltrials |
| NCT02431520 | Patient Compliance to Self-collection for Detection of HPV-DNA | completed | N/A | 100 | Oswaldo Cruz FoundationOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT02435888 | Predictive Equations for Resting Energy Expenditure | completed | — | 30 | Federal University of Minas GeraisOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT00582426 | Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea(LARCID) | completed | Phase 3 | 139 | Novartis PharmaceuticalsINDUSTRY | 1 | May 4, 2015 | clinicaltrials |
| NCT00427414 | Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma | terminated | Phase 1 | 14 | AIDS Malignancy ConsortiumNETWORK | 2 | Apr 29, 2015 | clinicaltrials |
| NCT01500720 | Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer | completed | Phase 2 | 179 | SanofiINDUSTRY | 16 | Apr 13, 2015 | clinicaltrials |
| NCT01941953 | Metformin and 5-fluorouracil for Refractory Colorectal Cancer. | completed | Phase 2 | 50 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 8, 2015 | clinicaltrials |
| NCT01217177 | A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer(PHOENIX I) | completed | Phase 1 | 14 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 3, 2015 | clinicaltrials |
| NCT00117598 | Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)(OPTIMAL) | completed | Phase 3 | 169 | PfizerINDUSTRY | 18 | Mar 30, 2015 | clinicaltrials |
| NCT00254904 | Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC | terminated | Phase 3 | 839 | PfizerINDUSTRY | 24 | Mar 30, 2015 | clinicaltrials |
| NCT00457691 | Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 768 | PfizerINDUSTRY | 34 | Mar 30, 2015 | clinicaltrials |
| NCT01450449 | Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme | completed | Phase 3 | 115 | International Atomic Energy AgencyOTHER_GOV | 14 | Mar 24, 2015 | clinicaltrials |
| NCT02363101 | Health Outcomes and Costs (HOC) in Lung Cancer (LC)(HOC-LC) | unknown | — | 300 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | Mar 4, 2015 | clinicaltrials |
| NCT00929240 | A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer | completed | Phase 3 | 287 | Hoffmann-La RocheINDUSTRY | 11 | Mar 3, 2015 | clinicaltrials |
| NCT00065325 | The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer(EFECT) | completed | Phase 3 | 694 | AstraZenecaINDUSTRY | 15 | Feb 24, 2015 | clinicaltrials |
| NCT00652366 | A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 467 | Hoffmann-La RocheINDUSTRY | 23 | Feb 11, 2015 | clinicaltrials |
| NCT01333852 | Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer(METTAX) | terminated | Phase 2 | 45 | Lucas Vieira dos SantosOTHER | 1 | Jan 27, 2015 | clinicaltrials |
| NCT00863746 | A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).(MISSION) | completed | Phase 3 | 703 | BayerINDUSTRY | 34 | Jan 19, 2015 | clinicaltrials |
| NCT00718315 | A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. | completed | Phase 3 | 201 | Hoffmann-La RocheINDUSTRY | 1 | Jan 15, 2015 | clinicaltrials |
| NCT00102804 | Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 663 | Eli Lilly and CompanyINDUSTRY | 20 | Dec 29, 2014 | clinicaltrials |
| NCT02308631 | Endoscopically Assisted Colostomy With Colopexy for Critically Ill Patients Without General Anesthesia or Laparotomy(EACC) | completed | Phase 1 | 5 | University of Sao PauloOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT01800643 | Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation | unknown | Phase 2 / Phase 3 | 100 | Hospital Israelita Albert EinsteinOTHER | 1 | Dec 3, 2014 | clinicaltrials |
| NCT01072045 | Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma | completed | Phase 2 | 50 | University of Sao PauloOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT01339260 | An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting | completed | Phase 3 | 1,455 | Helsinn Healthcare SAINDUSTRY | 15 | Nov 26, 2014 | clinicaltrials |
| NCT00761280 | Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma(SAPPHIRE) | terminated | Phase 3 | 27 | Isarna Therapeutics GmbHINDUSTRY | 16 | Nov 14, 2014 | clinicaltrials |
| NCT01067976 | Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI | completed | Phase 3 | 446 | BayerINDUSTRY | 9 | Nov 11, 2014 | clinicaltrials |
| NCT01041404 | ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer | completed | Phase 3 | 584 | Hoffmann-La RocheINDUSTRY | 24 | Nov 5, 2014 | clinicaltrials |
| NCT02283346 | Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial(AC-P01) | unknown | Phase 2 | 60 | AC Camargo Cancer CenterOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT00123487 | Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML | completed | Phase 3 | 638 | Bristol-Myers SquibbINDUSTRY | 32 | Nov 3, 2014 | clinicaltrials |
| NCT00324155 | Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma | completed | Phase 3 | 681 | Bristol-Myers SquibbINDUSTRY | 25 | Nov 3, 2014 | clinicaltrials |
| NCT00105443 | A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma(SHARP) | completed | Phase 3 | 602 | BayerINDUSTRY | 23 | Oct 31, 2014 | clinicaltrials |
| NCT02279758 | A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors(MetNet) | unknown | Phase 2 | 30 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT01941979 | A Study Comparing Adjuvant Chemotherapy Versus Observation for Patients With Rectal Adenocarcinoma After Neoadjuvant Chemo-Radiotherapy Treatment. | unknown | Phase 3 | 309 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Oct 30, 2014 | clinicaltrials |
| NCT02278861 | Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis(ARISOAK) | completed | Phase 2 | 60 | Universidade Federal de GoiasOTHER | 1 | Oct 30, 2014 | clinicaltrials |
| NCT02257827 | Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule | completed | Phase 3 | 220 | Gustavo Viani ArrudaOTHER | 1 | Oct 6, 2014 | clinicaltrials |
| NCT00720798 | An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies | completed | Phase 3 | 2,067 | Hoffmann-La RocheINDUSTRY | 34 | Sep 30, 2014 | clinicaltrials |
| NCT02250989 | The Influence of Glycaemia and Insulinemia on Vasomotor Endothelial Function After Myocardial Infarction(INGLIVEF) | unknown | — | 75 | University of Campinas, BrazilOTHER | 1 | Sep 26, 2014 | clinicaltrials |
| NCT02230059 | Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)(REALIST-PRO) | completed | — | 382 | Janssen Research & Development, LLCINDUSTRY | 1 | Sep 25, 2014 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials